首页> 外文期刊>Medical decision making: An international journal of the Society for Medical Decision Making >Breast cancer patients' treatment expectations after exposure to the decision aid program adjuvant online: the influence of numeracy.
【24h】

Breast cancer patients' treatment expectations after exposure to the decision aid program adjuvant online: the influence of numeracy.

机译:接触在线决策辅助程序后对乳腺癌患者的治疗期望:计算的影响。

获取原文
获取原文并翻译 | 示例
           

摘要

The decision aid called ''Adjuvant Online'' (Adjuvant! for short) helps breast cancer patients make treatment decisions by providing numerical estimates of treatment efficacy (e.g., 10-y relapse or survival). Studies exploring how patients' numeracy interacts with the estimates provided by Adjuvant! are lacking. Pooling across 2 studies totaling 105 women with estrogen receptor-positive, early-stage breast cancer, the authors explored patients' treatment expectations, perceived benefit from treatments, and confidence of personal benefit from treatments. Patients who were more numerate were more likely to provide estimates of cancer-free survival that matched the estimates provided by Adjuvant! for each treatment option compared with patients with lower numeracy (odds ratios of 1.6 to 2.4). As estimates of treatment efficacy provided by Adjuvant! increased, so did patients' estimates of cancer-free survival (0.37 > r(s) > 0.48) and their perceptions of treatment benefit from hormonal therapy (r(s) = 0.28) and combined therapy (r(s) = 0.27). These relationships were significantly more pronounced for those with higher numeracy, especially for perceived benefit of combined therapy. Results suggest that numeracy influences a patient's ability to interpret numerical estimates of treatment efficacy from decision aids such as Adjuvant!.
机译:名为“在线佐剂”(Adjuvant!)的决策辅助工具通过提供治疗效果(例如10年复发或存活)的数字估算值,帮助乳腺癌患者做出治疗决策。研究探索患者的算术如何与佐剂提供的估计值相互影响!缺乏。作者在2项研究中汇总了105位患有雌激素受体阳性,早期乳腺癌的女性,研究人员探讨了患者的治疗期望,从治疗中获得的收益以及从治疗中获得的个人收益的信心。人数更多的患者更有可能提供与佐剂提供的估计值相匹配的无癌存活率估计值!与算术较低的患者(赔率比为1.6到2.4)相比,每种治疗方案的治疗效果都更好。作为佐剂提供的治疗效果的估计!增加,患者对无癌生存的估计(0.37> r(s)> 0.48)和对治疗的看法也从激素疗法(r(s)= 0.28)和联合疗法(r(s)= 0.27)中受益。对于那些具有较高算术能力的人,尤其是对于联合治疗的明显益处,这些关系更为明显。结果表明,计算能力会影响患者从决策辅助工具(如佐剂)中解释治疗效果的数值估计的能力。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号